- Tytuł:
- Dipeptidyl peptidase-4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes.
- Autorzy:
- Źródło:
- Journal of diabetes investigation [J Diabetes Investig] 2021 Oct; Vol. 12 (10), pp. 1805-1815. Date of Electronic Publication: 2021 May 26.
- Typ publikacji:
- Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
- MeSH Terms:
-
Diabetes Mellitus, Type 2 /*drug therapy
Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use
Insulin/*metabolism
Liver/*metabolism
Pyrimidines/*therapeutic use
Aged ; Asian People ;Diabetes Mellitus, Type 2 /metabolism ; Dipeptidyl-Peptidase IV Inhibitors/pharmacology ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Pyrimidines/pharmacology
Czasopismo naukowe